Skip to content

APOTHEEK DE CAUSMAECKER: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK DE CAUSMAECKER

BE 0547.896.382
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€113,868
2024 · €120,130-€6,262
Equity
€316,264
2024 · €302,396+€13,868
Cash
€15,837
2024 · €99,326-€83,489
Balance sheet total
€408,937
2024 · €441,610-€32,673

Largest movements

2024 to 2025
Assets
  • Cash -€83,489

    down €83,489 (-84.1%), from €99,326 to €15,837

    mainly Contributions, distributions and other (-€100,000) and Other debts (-€72,354)

  • Tangible fixed assets +€30,215

    up €30,215 (+74.2%), from €40,737 to €70,952

    of which Furniture and vehicles: +€39,141

  • Receivables within one year +€23,820

    up €23,820 (+17.5%), from €136,419 to €160,240

    of which Other amounts receivable: +€34,220

  • Stocks and contracts -€5,244

    down €5,244 (-3.3%), from €158,649 to €153,405

Equity and liabilities
  • Other debts -€72,354

    down €72,354 (-100%), from €72,354 to €0

  • Trade debts +€23,795

    up €23,795 (+96.5%), from €24,656 to €48,451

  • Reserves +€13,000

    up €13,000 (+4.6%), from €281,860 to €294,860

    of which Distributable reserves: +€13,000

  • Tax, wage and social debts +€8,735

    up €8,735 (+24.9%), from €35,088 to €43,823

    of which Remuneration and social security: +€20,432

  • Accrued charges and deferred income -€6,717

    down €6,717 (-94.4%), from €7,116 to €400

Income statement
  • Gross operating margin -€28,907

    down €28,907 (-10.5%), from €276,365 to €247,458

  • Staff costs -€8,881

    down €8,881 (-9.9%), from €89,680 to €80,799

  • Depreciation -€6,729

    down €6,729 (-28.4%), from €23,663 to €16,934

  • Financial charges -€4,422

    down €4,422 (-46.2%), from €9,569 to €5,148

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €120,130
Gross operating margin -€28,907
Staff costs +€8,881
Depreciation +€6,729
Other operating charges -€59
Financial income +€380
Financial charges +€4,422
Taxes +€2,293
Result 2025 €113,868
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€63,661
Investment -€47,150
Financing -€100,000
Cash 2024 €99,326
Net result for the year +€113,868
Depreciation +€16,934
Stocks and contracts +€5,244
Receivables within one year -€23,820
Deferred charges and accrued income -€2,024
Trade debts +€23,795
Tax, wage and social debts +€8,735
Other debts -€72,354
Accrued charges and deferred income -€6,717
Investment in fixed assets (net) -€47,150
Contributions, distributions and other -€100,000
Cash 2025 €15,837
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €441,610 €408,937 -€32,673 -7.4%
Fixed assets 21/28 €40,737 €70,952 +€30,215 +74.2%
Intangible fixed assets 21 €0 - =
Tangible fixed assets 22/27 €40,737 €70,952 +€30,215 +74.2%
Plant, machinery and equipment 23 €40,737 €31,812 -€8,925 -21.9%
Furniture and vehicles 24 €0 €39,141 +€39,141
Current assets 29/58 €400,873 €337,985 -€62,888 -15.7%
Stocks and contracts in progress 3 €158,649 €153,405 -€5,244 -3.3%
Stocks 30/36 €158,649 €153,405 -€5,244 -3.3%
Amounts receivable within one year 40/41 €136,419 €160,240 +€23,820 +17.5%
Trade receivables 40 €135,276 €124,876 -€10,400 -7.7%
Other amounts receivable 41 €1,143 €35,363 +€34,220 +2,993%
Cash at bank and in hand 54/58 €99,326 €15,837 -€83,489 -84.1%
Deferred charges and accrued income 490/1 €6,479 €8,504 +€2,024 +31.2%
Total equity and liabilities 10/49 €441,610 €408,937 -€32,673 -7.4%
Equity 10/15 €302,396 €316,264 +€13,868 +4.6%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €281,860 €294,860 +€13,000 +4.6%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €280,000 €293,000 +€13,000 +4.6%
Profit (loss) carried forward 14 €1,936 €2,804 +€868 +44.8%
Amounts payable 17/49 €139,214 €92,673 -€46,541 -33.4%
Amounts payable within one year 42/48 €132,097 €92,273 -€39,824 -30.1%
Trade debts 44 €24,656 €48,451 +€23,795 +96.5%
Suppliers 440/4 €24,656 €48,451 +€23,795 +96.5%
Taxes, remuneration and social security 45 €35,088 €43,823 +€8,735 +24.9%
Taxes 450/3 €25,403 €13,706 -€11,697 -46.0%
Remuneration and social security 454/9 €9,685 €30,117 +€20,432 +211%
Other amounts payable 47/48 €72,354 €0 -€72,354 -100%
Accrued charges and deferred income 492/3 €7,116 €400 -€6,717 -94.4%
Remuneration, social security and pensions 62 €89,680 €80,799 -€8,881 -9.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €23,663 €16,934 -€6,729 -28.4%
Other operating charges 640/8 €629 €688 +€59 +9.4%
Gross operating margin 9900 €276,365 €247,458 -€28,907 -10.5%
Operating profit (loss) 9901 €162,392 €149,036 -€13,356 -8.2%
Financial income 75/76B €1,580 €1,960 +€380 +24.0%
Recurring financial income 75 €1,580 €1,960 +€380 +24.0%
Financial charges 65/66B €9,569 €5,148 -€4,422 -46.2%
Recurring financial charges 65 €9,569 €5,148 -€4,422 -46.2%
Profit (loss) for the period before taxes 9903 €154,403 €145,848 -€8,555 -5.5%
Income taxes 67/77 €34,273 €31,980 -€2,293 -6.7%
Profit (loss) for the period 9904 €120,130 €113,868 -€6,262 -5.2%
Profit (loss) for the period to be appropriated 9905 €120,130 €113,868 -€6,262 -5.2%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.